Fulgent Genetics, Inc. (NASDAQ:FLGT) Q3 2024 Earnings Call Transcript
Operator: Greetings and welcome to the Fulgent Genetics Q3 2024 Conference Call and Webcast. At this time, all participants are in a listen-only mode.
Fulgent Genetics Inc. (FLGT)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Millennium Management Israel Englander | 1,270,649 | $27,611,203 | +33% | 0.01% |
| 2. | Park West Asset Management Peter S. Park | 713,584 | $15,506,180 | -15% | 1.1% |
| 3. | Citadel Investment Group Ken Griffin | 302,918 | $6,582,408 | +63% | 0% |
| 4. | Point72 Asset Management Steve Cohen | 269,375 | $5,853,510 | 0.01% | |
| 5. | Invenomic Capital Management Ali Motamed | 249,747 | $5,427,002 | +99% | 0.29% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $4.95 | 8,739 | Large Shareholder, Officer, Director | 6,579,326 | 2019-03-05 | Filing | |
| $3.59 | 10,880 | Large Shareholder, Officer, Director | 6,570,587 | 2018-11-13 | Filing | |
| $3.36 | 10,000 | Large Shareholder, Officer, Director | 6,559,707 | 2018-11-09 | Filing | |
| $3.60 | 1,000 | Large Shareholder, Officer, Director | 1,000 | 2017-11-30 | Filing | |
| $3.60 | 1,000 | Large Shareholder, Officer, Director | 1,000 | 2017-11-30 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $21.96 | 1,674 | 209,481 | 2024-09-03 | Filing | ||
| $21.96 | 1,594 | 341,170 | 2024-09-03 | Filing | ||
| $21.96 | 1,503 | 923,057 | 2024-09-03 | Filing | ||
| $22.83 | 563 | 924,560 | 2024-08-27 | Filing | ||
| $22.83 | 715 | 342,764 | 2024-08-27 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 3,761,878 | $108,755,893 | 0% | |
| 2. | 1,447,153 | $41,838,725 | 0.01% | |
| 3. | 1,416,191 | $40,942,082 | 0% | |
| 4. | 1,000,000 | $28,910,000 | 0% | |
| 5. | 812,932 | $23,501,864 | 0% |
News See All
Fulgent Genetics, Inc. (NASDAQ:FLGT) Q2 2024 Earnings Call Transcript
Operator: Hello and welcome to the Fulgent Genetics Q2 2024 Conference Call and Webcast. [Operator Instructions] A question-and-answer session will follow the formal presentation.
Fulgent Genetics, Inc. (NASDAQ:FLGT) Q1 2024 Earnings Call Transcript
Fulgent Genetics, Inc. beats earnings expectations. Reported EPS is $-0.01, expectations were $-0.33. Fulgent Genetics, Inc.
Fulgent Genetics, Inc. (NASDAQ:FLGT) Q4 2023 Earnings Call Transcript
Fulgent Genetics, Inc. beats earnings expectations. Reported EPS is $0.28, expectations were $-0.3. Fulgent Genetics, Inc.
Fulgent Genetics, Inc. (NASDAQ:FLGT) Q3 2023 Earnings Call Transcript
Operator: Hello, and welcome to the Fulgent Genetics Q3 2023 Earnings Conference Call and Webcast. [Operator Instructions] A question-and-answer session will follow the formal presentation.
Top 20 Genomics Companies in the World
In this piece, we will take a look at the top 20 genomics companies in the world.
Fulgent Genetics, Inc. (NASDAQ:FLGT) Q2 2023 Earnings Call Transcript
Operator: Hello and welcome to the Fulgent Genetics Q2 2023 Earnings Conference Call and Webcast. [Operator Instructions] A question-and-answer session will follow the formal presentation.
10 DNA Stocks Billionaires Are Loading Up On
Genomics is the study of a complete set of DNA within an organism.
Fulgent Genetics, Inc. (NASDAQ:FLGT) Q1 2023 Earnings Call Transcript
Operator: Hello and welcome to the Fulgent Genetics Q1 2023 Earnings Conference Call and Webcast. [Operator Instructions] As a reminder, this conference is being recorded.
Fulgent Genetics, Inc. (NASDAQ:FLGT) Q4 2022 Earnings Call Transcript
Operator: Hello and welcome to the Fulgent Genetics Q4 and Fiscal Year 2022 Earnings Conference Call and Webcast. As a reminder, this conference is being recorded.
Billionaire Hedge Funds
